BehaveNet^® Clinical Capsule™:

drug: lamotrigine

• Clinical class: Anticonvulsant
• Psychiatric uses: mood stabilizer, bipolar depression
• Action: inhibits voltage-sensitive sodium channels, glutamate and aspartate release inhibition, stabilization of presynaptic membrane, excitatory neurotransmitter release inhibition
• Chemical class: phenyltriazine
• Active metabolite: none
• CSA schedule: none
• DEA number: none
• MEDLINEplus^® Drug Information

U.S. Preparations:

• Lamictal^® (GlaxoSmithKline) FDA approved for: 
  8.24.98 adjunctive treatment of partial seizures in adults; adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients
  12.14.98 conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing anti-epileptic drug (EIAED)
  6.20.2003 the maintenance treatment of Bipolar I Disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy
  9.22.2006 treatment of primary generalized tonic clonic seizures in adults and pediatric patients (2 years of age or older)
  WARNING I
  WARNING II
  U.S. Prescribing information

Preparations Outside U.S.:

• Labileno, Lamictin

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2007 BehaveNet®